Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Aug;79(8):2964-73.
doi: 10.1128/IAI.00047-11. Epub 2011 May 16.

Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens

Affiliations
Review

Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens

Joshua C Cyktor et al. Infect Immun. 2011 Aug.

Abstract

The generation of an effective immune response against an infection while also limiting tissue damage requires a delicate balance between pro- and anti-inflammatory responses. Interleukin-10 (IL-10) has potent immunosuppressive effects and is essential for regulation of immune responses. However, the immunosuppressive properties of IL-10 can also be exploited by pathogens to facilitate their own survival. In this minireview, we discuss the role of IL-10 in modulating intracellular bacterial, fungal, and parasitic infections. Using information from several different infection models, we bring together and highlight some common pathways for IL-10 regulation and function that cannot be fully appreciated by studies of a single pathogen.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
The interplay between pathogen and host dictates the requirements for IL-10. The initial interaction between the pathogen and host likely dictates the necessity for the immunoregulatory role of IL-10. (A) If pathogen recognition leads to proinflammatory responses that can rapidly and successfully eradicate the pathogen, the anti-inflammatory properties of IL-10 are minimal and an IL-10 blockade or removal has little effect on disease outcome. (B) If pathogen recognition triggers a strong inflammatory response with abundant TNF, IL-10 is essential to counter this reaction and prevent tissue damage. The removal of IL-10 leads to a severe immunopathology that is frequently lethal. (C) For pathogens that are able to avoid killing by host cells, a balance is established between the generation of proinflammatory responses to eradicate the pathogen and anti-inflammatory responses to limit inflammation. In this instance, pathogen-driven IL-10 production can establish persistence.
Fig. 2.
Fig. 2.
IL-10 and the balance between apoptosis and pathogen persistence. The presence or absence of IL-10 in infected tissue dictates not only the strength of the immune response but subsequently the amount of apoptosis incurred due to inflammation. A heavily inflamed apoptotic environment is not conducive to pathogen survival; thus, some pathogens induce IL-10 via pattern recognition receptors (PRRs) to subvert the development of acute inflammation. An abundance of IL-10 in the infected tissue decreases activation-induced inflammation and apoptosis, allowing the pathogen to persist intracellularly. If IL-10 is not induced, or it is removed, the inflammation that develops is robust enough to clear the infection, but high levels of apoptosis and parenchymal damage consequently occur.

References

    1. Ananieva O., et al. 2008. The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. Nat. Immunol. 9:1028–1036 - PubMed
    1. Araujo F. F., et al. 2007. Potential role of CD4+CD25HIGH regulatory T cells in morbidity in Chagas disease. Front. Biosci. 12:2797–2806 - PubMed
    1. Beamer G. L., et al. 2008. Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J. mice. J. Immunol. 181:5545–5550 - PMC - PubMed
    1. Belkaid Y., et al. 2001. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194:1497–1506 - PMC - PubMed
    1. Belkaid Y., Piccirillo C. A., Mendez S., Shevach E. M., Sacks D. L. 2002. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420:502–507 - PubMed